Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 25461 - 25480 out of 485193 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL syringe | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (S01LA05) aflibercept | Eylea 2 mg/0.05 mL injection, 0.05 mL vial | Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | BayerAustraliaLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Maxor 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AlphapharmPtyLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Omeprazole (Apo) 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ApotexPtyLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Omeprazole (Pharmacor) 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | PharmacorPtyLimited |
| Australia | (A02BC01) omeprazole (adm: O) | Omeprazole (Sandoz) 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Omeprazole (WGR) 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | WAGNERPHARMACEUTICALSPTYLTD |
| Australia | (A02BC01) omeprazole (adm: O) | Pemzo 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | ArrowPharmaPtyLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Probitor 20 mg enteric capsule, 30 | Capsule 20 mg, 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | SandozPtyLtd |
| Australia | (A02BC01) omeprazole (adm: O) | Acimax 20 mg enteric tablet, 30 | Tablet 20 mg (as magnesium), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | Pharmaco(Australia)Limited |
| Australia | (A02BC01) omeprazole (adm: O) | Losec 10 mg enteric tablet, 30 | Tablet 10 mg (as magnesium), 30 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | Pharmaco(Australia)Limited |
Pages
